Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Marksans Pharma Limited
MARKSANSMarksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, upper respiratory, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. It also produces a range of solid oral dosage forms, including tablets and hard gelatin capsules; soft gels; essential oils; ointments; and creams and liquids, as well as prescription drugs. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India. Address: Grandeur, Mumbai, India, 400053
Analytics
WallStreetin tavoitehinta
2 617.34 INRP/E-suhde
40.8144Osinkotuotto
0.2 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut MARKSANS
Osinkoanalytiikka MARKSANS
Osinkojen kasvu 5 vuoden aikana
900 %Jatkuva kasvu
1 vuosiMaksusuhde 5 vuoden keskiarvo
5 %Osinkohistoria MARKSANS
Osakkeen arvostus MARKSANS
Talousasiat MARKSANS
Tuloksia | 2019 | Dynamiikka |